Insider Transactions in Q4 2022 at Provention Bio, Inc. (PRVB)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2022
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
187,000
-10.63%
|
$1,870,000
$10.26 P/Share
|
Dec 29
2022
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
187,000
+9.6%
|
$374,000
$2.5 P/Share
|
Dec 27
2022
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,674
-0.67%
|
$106,740
$10.0 P/Share
|
Dec 27
2022
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,674
+0.67%
|
$21,348
$2.5 P/Share
|
Dec 23
2022
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
375
-0.02%
|
$3,750
$10.0 P/Share
|
Dec 23
2022
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
375
+0.02%
|
$750
$2.5 P/Share
|
Dec 22
2022
|
Francisco Leon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,568
-0.1%
|
$15,680
$10.0 P/Share
|
Dec 22
2022
|
Francisco Leon Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,568
+0.1%
|
$3,136
$2.5 P/Share
|